Study of Verinurad in Heart Failure With Preserved Ejection Fraction
Clinical trial NCT04327024 · COMPLETED
Trial details
- NCT number
- NCT04327024
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-19
- Primary completion
- 2022-04-29
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.